Lung India最新文献

{"title":"A young male with non-resolving consolidation and hepatosplenomegaly.","authors":"Pradeep Bajad, Sourabh Pahuja, Satyam Agarwal, Gaurav Khanna, Arjun Khanna","doi":"10.4103/lungindia.lungindia_417_23","DOIUrl":"10.4103/lungindia.lungindia_417_23","url":null,"abstract":"<p><strong>Abstract: </strong>Non-resolving consolidation refers to the persistence of radiographic abnormalities beyond the anticipated timeframe. Conditions such as infection, malignancy, inflammatory disorders, and connective tissue diseases can all manifest as non-resolving consolidation. We share a clinicopathological case study involving a 30-year-old male who exhibits non-resolving consolidation accompanied by hepatosplenomegaly.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"299-304"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of alpha-defensins as a marker of severity in chronic obstructive pulmonary disease.","authors":"Kritika Kumar, Komaldeep Kaur, Shivani Jaswal, Deepak Aggarwal, Varinder Saini","doi":"10.4103/lungindia.lungindia_395_23","DOIUrl":"10.4103/lungindia.lungindia_395_23","url":null,"abstract":"<p><strong>Background: </strong>Defensins are key effector molecules of innate immunity that can contribute towards the diagnosis and monitoring of chronic obstructive pulmonary disease (COPD). The present study was conducted to investigate the role of alpha-defensins in patients with COPD by quantifying serum and sputum samples.</p><p><strong>Methods: </strong>A total of 180 patients were enrolled and divided into four groups, and sputum and serum values of alpha-defensins were assessed. The sensitivity, specificity, and accuracy of sputum alpha-defensin as a diagnostic biomarker were evaluated to assess its utility in diagnosing COPD.</p><p><strong>Results: </strong>The mean value of sputum alpha-defensins was found to be statistically significant amongst the four groups (P < 0.001). The highest levels were found in subjects with AECOPD (385.76 ± 116.62 ng/mL). Sputum alpha-defensins were found to be negatively correlated with FEV 1 values (rho = -0.31, P < 0.001).</p><p><strong>Conclusion: </strong>Sputum alpha-defensins can be used as a potential marker for predicting acute exacerbation of COPD. In addition, they could serve as an indicator of disease severity in COPD patients.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"259-264"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Positive airway pressure (PAP) as a remedy for treatment-resistant migraine - A case report.","authors":"Bavneet Kaur, Kaustav Kundu, Purushottam Singh, Lokesh K Saini, Ravi Gupta","doi":"10.4103/lungindia.lungindia_22_24","DOIUrl":"10.4103/lungindia.lungindia_22_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"322-324"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024).","authors":"Parvaiz A Koul, Agam C Vora, Surinder K Jindal, Venkatasubramanian Ramasubramanian, Varsha Narayanan, Surya Kant Tripathi, Digambar Bahera, Harway Bhaskar Chandrashekhar, Ravindra Mehta, Narendra Raval, Prabhakar Dorairaj, Prashant Chhajed, Akash Balki, Rohan Ketan Aurangabadwalla, Abhijeet Khandelwal, Mahendra Kawedia, Satya Prakash Rai, Ashok Grover, Manish Sachdev, Surajit Chatterjee, Velamuru V Ramanaprasad, Aratrika Das, Mahavir Madhavdas Modi","doi":"10.4103/lungindia.lungindia_8_24","DOIUrl":"10.4103/lungindia.lungindia_8_24","url":null,"abstract":"<p><strong>Introduction: </strong>Pneumococcal diseases pose a significant public health concern in India, with substantial morbidity and mortality, with the elderly and those with coexisting medical conditions being most at risk. Pneumococcus was also seen to be one of the main reasons for co-infection, pneumonia and complications in COVID. Current guidelines recommend vaccination for specific adult populations, but there is a lack of uniformity and guidance on risk stratification, prioritisation and optimal timing.</p><p><strong>Methods: </strong>Nation Against Pneumococcal Infections - Expert Panel Opinion (NAP-EXPO) is a panel convened to review and update recommendations for adult pneumococcal vaccination in India. The panel of 23 experts from various medical specialties engaged in discussions and evidence-based reviews, discussed appropriate age for vaccination, risk stratification for COPD and asthma patients, vaccination strategies for post-COVID patients, smokers and diabetics, as well as methods to improve vaccine awareness and uptake.</p><p><strong>Outcome: </strong>The NAP-EXPO recommends the following for adults: All healthy individuals 60 years of age and above should receive the pneumococcal vaccine; all COPD patients, regardless of severity, high-risk asthma patients, post-COVID cases with lung fibrosis or significant lung damage, should be vaccinated with the pneumococcal vaccine; all current smokers and passive smokers should be educated and offered the pneumococcal vaccine, regardless of their age or health condition; all diabetic individuals should receive the pneumococcal vaccine, irrespective of their diabetes control. Strategies to improve vaccine awareness and uptake should involve general practitioners (GPs), primary health physicians (PHPs) and physicians treating patients at high risk of pneumococcal disease. Advocacy campaigns should involve media, including social media platforms.</p><p><strong>Conclusion: </strong>These recommendations aim to enhance pneumococcal vaccination coverage among high-risk populations in India in order to ensure a reduction in the burden of pneumococcal diseases, in the post-COVID era. There is a need to create more evidence and data to support the recommendations that the vaccine will be useful to a wider range of populations, as suggested in our consensus.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"307-317"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of COVID-19 pandemic on influenza vaccine uptake.","authors":"Vidya B Nair, Sujith Varghese Abraham, Arjun Padmanabhan","doi":"10.4103/lungindia.lungindia_510_23","DOIUrl":"10.4103/lungindia.lungindia_510_23","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"327-328"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302790/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The severity of non-smoking chronic obstructive pulmonary disease is correlated with biomass fuel exposure and COPD assessment test score.","authors":"Anuj Kumar Pandey, Ajay Kumar Verma, Arpita Singh, Surya Kant, Shyam Chand Chaudhary, Jyoti Bajpai, Rakesh Kumar Dixit","doi":"10.4103/lungindia.lungindia_304_23","DOIUrl":"10.4103/lungindia.lungindia_304_23","url":null,"abstract":"<p><strong>Background and objective: </strong>Tobacco smoking is an established risk factor for chronic obstructive pulmonary disease (COPD). Current evidence suggests that non-tobacco-related risk factors vary geographically and are less understood than smoking. This study aims to compare the risk factors, symptoms, and clinical features of smoking (S-COPD) and non-smoking (NS-COPD) in a COPD population.</p><p><strong>Materials and methods: </strong>In this retrospective cross-sectional study, 489 COPD patients were screened. Data on socio-demographics, smoking and medical history, other risk factors, symptoms, and clinical characteristics including COPD Assessment Test (CAT) score, and Modified Medical Research Council (mMRC) Dyspnea Scale were examined.</p><p><strong>Results: </strong>Of the total selected 416 COPD patients, 35.34% were NS-COPD while 64.66% were S-COPD. S-COPD was predominant in males, whereas NS-COPD was predominant in females (P < 0.0001). In NS-COPD, biomass fuel exposure was a major risk factor (P < 0.0001), and 61% of subjects had a biomass fuel exposure index of >60. In bivariate and multivariate analyses, no risk factors were correlated with forced expiratory volume in 1 second (FEV1)% predicted, while among clinical features, duration of illness (P = 0.001) was correlated with lower values of FEV1 in the multivariate table of S-COPD. In the multivariate analysis, biomass fuel exposure (P = 0.039) and CAT score (P < 0.0001) were correlated with FEV1(%) in NS-COPD.</p><p><strong>Conclusion: </strong>Biomass fuel exposure is a substantial risk factor for NS-COPD and was correlated with FEV1(%) predicted. In addition, the CAT score correlated with disease severity in patients with NS-COPD. The development of COPD in non-smokers is being recognized as a separate phenotype and it should be managed according to risk factors.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"251-258"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"'You bleed in war and you bleed in peace: Hemoptysis in a case with retained intra-thoracic bullet fragments decades after the injury'.","authors":"V Shrinath, S Vignesh, Somnath Pan, R Ananthakrishnan","doi":"10.4103/lungindia.lungindia_525_23","DOIUrl":"10.4103/lungindia.lungindia_525_23","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"331-332"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Shedding light on the prevalence of co-morbid insomnia and obstructive sleep apnoea.","authors":"Himanshu Garg, Prerana Garg","doi":"10.4103/lungindia.lungindia_228_24","DOIUrl":"10.4103/lungindia.lungindia_228_24","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"249-250"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of co-morbid insomnia and obstructive sleep apnoea.","authors":"Swapnil Manaji Thorve, Manish Yadav, Anjali Arvind Kamath, Jairaj Parmeswaran Nair","doi":"10.4103/lungindia.lungindia_555_23","DOIUrl":"10.4103/lungindia.lungindia_555_23","url":null,"abstract":"<p><strong>Introduction: </strong>The coexistence of insomnia and obstructive sleep apnea (OSA) poses a complex and challenging clinical scenario, commonly referred to as comorbid insomnia and OSA (COMISA). The bidirectional relationship between these two sleep disorders is explored, illuminating how the presence of one can exacerbate the severity and manifestations of the other. We under took this study to understand the prevalence of COMISA in Indians which is never studied.</p><p><strong>Aim: </strong>To study the prevalence of COMISA in tertiary hospital in India.</p><p><strong>Methods: </strong>All OSA patients diagnosed with polysomnography were interviewed with insomnia severity index. Patients having score of more than 15 were considered to have insomnia. Demographic factors, clinical and physical examination and polysomnography values were noted.</p><p><strong>Results: </strong>25% of 64 patients were diagnosed to have COMISA. Female gender, BMI, and STOP BANG score had positive association with COMISA, whereas age was not associated with increased risk.</p><p><strong>Conclusion: </strong>COMISA can be more complex to diagnose and manage than insomnia or OSA alone. The symptoms and mechanisms of each condition have synergistic effect and is a barrier to treating COMISA.</p>","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"272-277"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glycopyrronium inhalation, bronchodilator reversibility assessment, and defining asthma: A new paradigm.","authors":"Parthasarathi Bhattacharyya, Srijita Sen, Shuvam Ghosh","doi":"10.4103/lungindia.lungindia_461_23","DOIUrl":"10.4103/lungindia.lungindia_461_23","url":null,"abstract":"","PeriodicalId":47462,"journal":{"name":"Lung India","volume":"41 4","pages":"328-329"},"PeriodicalIF":1.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}